TIDMGSK

RNS Number : 9116Q

GlaxoSmithKline PLC

02 March 2021

   GlaxoSmithKline plc   (the ' Company ') 

Vesting of Deferred Annual Bonus Plan Deferred Bonus Awards and Sale of Ordinary Shares and American Depository Shares

This notification sets out the vesting details for Persons Discharging Managerial Responsibilities ('PDMRs') of Deferred Bonus Awards over Ordinary Shares and American Depositary Shares ('ADSs') made in 2018 under the GlaxoSmithKline 2017 Deferred Annual Bonus Plan ('DABP') and subsequent sale of Ordinary Shares and ADSs to meet tax liabilities. In accordance with the shareholder approved 2017 Remuneration Policy and the DABP rules, the awards were comprised of a mandatory bonus deferral only. The three-year restricted period for the Deferred Bonus Awards commenced on 1 March 2018 and ended on 1 March 2021. Dividends accrued on the Awards during the restricted period.

The awards were granted in 2018 as restricted awards over ADSs for US participants and as nil-cost options over Ordinary Shares for all other participants.

The closing prices of Ordinary Shares and of ADSs of GlaxoSmithKline plc on 1 March 2021 were GBP12.0060 and $33.73.

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Ms E Walmsley 
====  ========================================  ==================================================== 
 b)    Position/status                          Chief Executive Officer 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                68,716 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.1070                                                             32,346 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr R Connor 
====  ========================================  ==================================================== 
 b)    Position/status                          President, Global Vaccines 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                14,551 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.1113                                                             6,857 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr N Hirons 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP, Global Ethics and Compliance 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                7,630 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics and Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.1132                                                             3,599 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                     Mr B McNamara 
====  ========================================  ============================================== 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  ============================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ============================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ============================================== 
 b)    Nature of the                            The vesting of an award granted in 2018 
        transaction                              under the Company's 2017 Deferred Annual 
                                                 Bonus Plan. 
====  ========================================  ============================================== 
 c)    Price(s) and                              Price(s)             Volume(s) 
        volume(s) 
====  ========================================   ===================  ====================== 
                                                 $0.00                7,346 
                                                 ===================  ====================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 =========================================  ================================================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ============================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ============================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================== 
 a)    Name                                     Mr B McNamara 
====  ========================================  ================================================ 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  ================================================ 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================ 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================ 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================ 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ================================================ 
 b)    Nature of the                            The sale of ADSs' to meet tax liabilities 
        transaction                              on the vesting of an award granted in 2018 
                                                 under the Company's 2017 Deferred Annual 
                                                 Bonus Plan. 
====  ========================================  ================================================ 
 c)    Price(s) and                              Price(s)              Volume(s) 
        volume(s) 
====  ========================================   ====================  ======================= 
                                                 $33.7970              3,756 
                                                 ====================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 =========================================  ==================================================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ================================================ 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================ 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr L Miels 
====  ========================================  ==================================================== 
 b)    Position/status                          President, Global Pharmaceuticals 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                13,820 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr L Miels 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.0992                                                             6,501 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr D Redfern 
====  ========================================  ==================================================== 
 b)    Position/status                          Chief Strategy Officer 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                14,126 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr D Redfern 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.1093                                                             6,656 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ======================================================================================== 
 a)    Name                                     Ms K Terrell 
====  ========================================  ============================================== 
 b)    Position/status                          Chief Digital & Technology Officer 
====  ========================================  ============================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ============================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ======================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ============================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ============================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ======================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ============================================== 
 b)    Nature of the                            The vesting of an award granted in 2018 
        transaction                              under the Company's 2017 Deferred Annual 
                                                 Bonus Plan. 
====  ========================================  ============================================== 
 c)    Price(s) and                              Price(s)             Volume(s) 
        volume(s) 
====  ========================================   ===================  ====================== 
                                                 $0.00                2,480 
                                                 ===================  ====================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 =========================================  ================================================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ============================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ============================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================== 
 a)    Name                                     Ms K Terrell 
====  ========================================  ================================================ 
 b)    Position/status                          Chief Digital & Technology Officer 
====  ========================================  ================================================ 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================ 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================ 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================ 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial 
        instrument                               ISIN: US37733W1053 
====  ========================================  ================================================ 
 b)    Nature of the                            The sale of ADSs' to meet tax liabilities 
        transaction                              on the vesting of an award granted in 2018 
                                                 under the Company's 2017 Deferred Annual 
                                                 Bonus Plan. 
====  ========================================  ================================================ 
 c)    Price(s) and                              Price(s)              Volume(s) 
        volume(s) 
====  ========================================   ====================  ======================= 
                                                 $33.7970              976 
                                                 ====================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 =========================================  ==================================================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ================================================ 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================ 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr P Thomson 
====  ========================================  ==================================================== 
 b)    Position/status                          President, Global Affairs 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument 
                                                 ISIN: GB0009252882 
====  ========================================  ==================================================== 
 b)    Nature of the                            The vesting of an award in the form of 
        transaction                              a nil-cost option over Ordinary Shares 
                                                 granted in 2018 under the Company's 2017 
                                                 Deferred Annual Bonus Plan and the subsequent 
                                                 exercise of the nil-cost option. 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ======================== 
   GBP0.00                                                                9,555 
   =====================================================================  ======================== 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  =============================== 
 e)    Date of the transaction                  2021-03-01 
====  ========================================  ==================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          The sale of Ordinary Shares to meet tax 
        transaction                            liabilities on the exercise of a nil-cost 
                                               option award granted in 2018 under the 
                                               Company's 2017 Deferred Annual Bonus Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP12.1030                                                             4,507 
   =====================================================================  =================== 
 
 d)    Aggregated information                 N/A (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2021-03-01 
====  ======================================  ================================================= 
 f)    Place of the                           N/A 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHELLFBFXLZBBQ

(END) Dow Jones Newswires

March 02, 2021 10:48 ET (15:48 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.